The Community Oncology Conference is pleased to partner with Imedex to offer continuing medical education (CME), Maintenance of Certification (MOC), and other professional credits to attendees. See below and stay tuned for more on how to submit documentation such as evaluations and certificates of attendance.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Imedex and Community Oncology Alliance. Imedex is accredited by the ACCME to provide continuing medical education for physicians. This activity has been approved for AMA PRA Category 1 CreditTM.
Maintenance of Certification
Successful completion of this CME activity enables a participant to earn MOC points towards the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is Imedex’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC Points.
An application to award nursing contact hours at this activity will be submitted to the Oncology Nursing Society. The Oncology Nursing Society is an accredited approver by the American Nurses Credentialing Center’s COA.
This activity is eligible for ACPE credit; see final CPE activity announcement for specific details. Imedex, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Disclosures & Disclaimers
Disclosure of Relevant Financial Relationships
Imedex and Community Oncology Alliance assess the relevant financial relationships of its presenters, planners, managers, and other individuals who are in a position to control the content of CME activities. Any potential conflicts of interest that are identified are thoroughly vetted by Imedex for fairness, balance, and scientific objectivity of data, as well as patient care recommendations. Imedex assumes final responsibility for all content presented at this activity. Imedex is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial entity.
Disclosure of Unlabeled Use
This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the Food and Drug Administration (FDA) of the United States. Participants are encouraged to consult the FDA-approved product labeling for any drug or device mentioned in this program before use. The opinions expressed in this document are the opinions of the abstract authors and do not necessarily reflect the opinions of Imedex, LLC or Community Oncology Alliance.
In addition, the material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.